logo
Thad Brown: Bosa best idea for what Bills needed this offseason

Thad Brown: Bosa best idea for what Bills needed this offseason

Yahoo12-03-2025

Joey Bosa comes to Buffalo for one year and a reported $12.6 million dollars. He also comes with a gigantic amount of risk that's to three seasons of relentless injury.
Sports Director Thad Brown explains why the risk is well worth the swing for Brandon Beane and the Bills. There is an opportunity to protect Bosa with the right plan. No matter the concern, this was the right move for the Bills. And perhaps the only they could make to finally get over the Super Bowl hump.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Brett Favre's heartfelt reaction to Vikings legend Jim Marshall's passing
Brett Favre's heartfelt reaction to Vikings legend Jim Marshall's passing

Yahoo

time24 minutes ago

  • Yahoo

Brett Favre's heartfelt reaction to Vikings legend Jim Marshall's passing

The post Brett Favre's heartfelt reaction to Vikings legend Jim Marshall's passing appeared first on ClutchPoints. Jim Marshall left a massive imprint on the football world, embodying the toughness and ferocity that defined the sport for so many decades. His legacy is especially powerful for those who have represented or rooted for the Minnesota Vikings. Current and former members of the organization sent their condolences following Marshall's passing on Tuesday. Advertisement Brett Favre, who donned the Purple and Gold for the last two years of his Hall of Fame career, can understand what it means to withstand grueling punishment year after year for the love of the game. He also knows what this man meant to The Gopher State. The Super Bowl-winning quarterback shared some kind words and reflected on No. 70's enduring impact. 'Man, I'll never forget the day I got to meet Jim Marshall — one of the true original Iron Men of the NFL,' Favre posted on X. 'Tough as nails, played 282 consecutive games as a defensive end… in an era when the game was as gritty and raw as it gets. 'Growing up watching guys like Jim, I learned what it meant to show up every single Sunday, no matter what. To have had the chance to shake his hand — and even play in front of him — was a real honor. 'Guys like Jim paved the way. They didn't ask for attention, they earned respect with every snap. I tried to bring that same mindset to the field every week. My condolences go out to him and his family — but he's certainly a legend among legends.' What Jim Marshall gave to the Vikings and their endlessly loyal fans Marshall's 270 consecutive starts rank only behind Favre's 297. The longtime defensive end congratulated the gunslinger in person for breaking his record, for he knows the physical and mental sacrifice required to post such an astonishing attendance record. Though, Marshall did far more than simply show up. Advertisement The No. 44 overall pick in the 1960 NFL Draft played 19 of his 20 seasons with Minnesota (began career with Cleveland Browns) and was a pivotal member of the iconic Purple People Eaters defense, which also consisted of Alan Page, Carl Eller and Gary Larsen. Marshall served a vital role during what is still the greatest era of Vikings football, helping the team reach the Super Bowl four separate times. Unfortunately, the team and community are still waiting for their first Lombardi Trophy. When impatience rises throughout Minneapolis, it is good to revisit or learn about the prosperous 1970s. Jim Marshall, who died at the age of 87 after a lengthy stay in the hospital, is responsible for so many of those memories. Yes, he also produced many chuckles via his infamous 'Wrong Way Run' in 1964, but the two-time Pro Bowl selection helped set the stage for the defensive warriors who have come after him, just as Favre noted. Marshall recorded 130.5 unofficial sacks (was not counted as a stat until 1982) and 29 opponent fumble recoveries in his storied NFL career. More than the numbers he accumulated, however, he breathed life into the Minnesota Vikings. The beloved captain was an inaugural member of the franchise and stayed connected to the team well after his retirement. He inspired Brett Favre and so many others, and by the sound of it, they will do their part to make sure his invaluable contributions are properly recognized moving forward. Related: Purple People Eaters legend who played 270 straight games passes away Related: 3 Minnesota Vikings hidden gems on 2025 roster you need to know

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo

time36 minutes ago

  • Yahoo

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif., June 11, 2025--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on June 10, 2025, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 115,620 shares of common stock and 57,740 restricted stock units ("RSUs") to 10 new employees under Mirum's 2020 Inducement Plan. The Compensation Committee of Mirum's Board of Directors approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4). Each stock option has an exercise price per share equal to $48.98 per share, Mirum's closing trading price on June 10, 2025, and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the underlying shares vesting monthly thereafter over 36 months, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The RSUs will vest over three years, with 33% of the underlying shares vesting on each anniversary of the applicable vesting commencement date, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The awards are subject to the terms and conditions of Mirum's 2020 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder. To learn more about Mirum, visit and follow Mirum on Facebook, LinkedIn, Instagram and X. View source version on Contacts Investor Contact: Andrew McKibbenir@ Media Contact: Erin Murphymedia@

Studio 17 Spotlights Kern County SHRM Annual Conference
Studio 17 Spotlights Kern County SHRM Annual Conference

Yahoo

timean hour ago

  • Yahoo

Studio 17 Spotlights Kern County SHRM Annual Conference

Presented by: Kern County SHRM On today's Studio 17, Kait Hill spoke with with Jackie Andrade, Conference Director, and Sky Newton, Conference Vice Chair, from Kern County SHRM to discuss their upcoming annual conference. Kern County SHRM plays a key role in connecting the local business community through leadership, professional development, and networking. With a long-standing presence in the region, Kern County SHRM's conference promises powerful keynote speakers and fresh topics that reflect the evolving workplace. The event welcomes not only HR professionals but anyone interested in career growth and leadership skills. Attendees can look forward to dynamic sessions and a vibrant atmosphere that encourages learning and connection. For those wanting to get involved year-round or register for the conference, more information is available on the . Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store